Schedule 13D ownership disclosure

RTI Biologics, Inc.

Security class unavailable · CUSIP: 74975N105

Event date: 2019-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,650,452
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-060552
Form type
SC 13D
Filer
Glen Capital Partners Focus Fund, L.P.
CIK
CIK 1572382
Filed
Nov 06, 2019
Reporting period
Nov 04, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub